Tozasertib induced a G2/M cell cycle block in p53 wild-type and p53-mutant neuroblastoma cell lines but with different kinetics and concentration-dependencies (Figure 5B) and induced more or less pronounced signs of endoreduplication (Figure 5B). The gene discussed is TP53; the disease is neuroblastoma.